Subtype
Meningeal Neoplasm
CI-CAN-00001210Explore in graph →
Non-malignant111 active trials2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001210Explore in graph →
Clinical trials
275 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06377371 | Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE | recruiting | Phase 4 | 20 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04081701 | 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.(DOMINO-START) | recruiting | Phase 4 | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | Nov 21, 2025 |
| clinicaltrials |
| NCT07092202 | Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases | recruiting | Phase 4 | 40 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT04386642 | Tranexamic Acid Reduce Blood Loss in Meningioma Resection | unknown | Phase 4 | 44 | Chiang Mai UniversityOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04356118 | Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis | unknown | Phase 4 | 30 | Hui BuOTHER | 0 | May 27, 2020 | clinicaltrials |
| NCT04356222 | Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis | unknown | Phase 4 | 30 | Hui BuOTHER | 0 | May 27, 2020 | clinicaltrials |
| NCT02590510 | Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis | unknown | Phase 4 | 50 | Hui BuOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT00029523 | DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor | completed | Phase 4 | 100 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Feb 28, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Feb 27, 2026source: clinicaltrials